25369411000001103: Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Haloperidol\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Haloperidol\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing haloperidol\Haloperidol\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing haloperidol\Haloperidol\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing haloperidol\Product containing haloperidol in oral dose form (medicinal product form)\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing haloperidol\Haloperidol\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing haloperidol\Haloperidol\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing haloperidol\Product containing haloperidol in oral dose form (medicinal product form)\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing haloperidol in oral dose form (medicinal product form)\Product containing only haloperidol in oral dose form (medicinal product form)\Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution\Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

80524701000001115 Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

80524801000001112 Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Is a	Product containing precisely haloperidol 1 milligram/1 milliliter conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has active ingredient	Haloperidol	false	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has specific active ingredient	Haloperidol	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release oral solution	true	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has excipient	Hydroxybenzoates	false	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) 100 ml	Has AMP	True	Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
80524701000001115	Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
80524801000001112	Haloperidol 5mg/5ml oral solution sugar free (Rosemont Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module